A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function. [electronic resource]
Producer: 20090430Description: 23-32 p. digitalISSN:- 1399-0012
- Antibodies, Monoclonal -- therapeutic use
- Basiliximab
- Cyclosporine -- therapeutic use
- Delayed Graft Function
- Drug Therapy, Combination
- Female
- Graft Rejection -- drug therapy
- Graft Survival -- drug effects
- Humans
- Immunosuppressive Agents -- therapeutic use
- Kidney Function Tests
- Kidney Transplantation
- Male
- Middle Aged
- Mycophenolic Acid -- analogs & derivatives
- Prospective Studies
- Recombinant Fusion Proteins -- therapeutic use
- Risk Factors
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.